| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Sales | $2.07B-4.0% | $2.15B-0.0% | $2.16B |
| Cost of sales | -$1.03B+1.4% | -$1.04B-0.6% | -$1.04B |
| Gross profit | $1.04B-6.5% | $1.11B-0.7% | $1.12B |
| Selling, general, and administrative | -$616.6M-11.7% | -$552.1M-23.7% | -$446.4M |
| Research and development | -$165.0M-0.9% | -$163.5M-1.2% | -$161.5M |
| Gain on sale of property | $0-100.0% | $63.1M | $0 |
| Goodwill impairment | -$1.44B | $0 | $0 |
| Operating (loss) profit | -$1.18B-357.4% | $459.6M-10.2% | $511.8M |
| Interest expense, net | -$32.3M | $0 | $0 |
| Loss from divestiture | $0+100.0% | -$25.6M | $0 |
| Other non-operating expenses, net | -$1.1M+21.4% | -$1.4M+30.0% | -$2.0M |
| (Loss) earnings before income taxes | -$1.22B-381.2% | $432.6M-15.1% | $509.8M |
| Income tax expense | -$6.1M+92.2% | -$78.0M+16.1% | -$93.0M |
| Net (loss) earnings | -$1.22B-444.8% | $354.6M-14.9% | $416.8M |
| Basic (in dollars per share) | -$10840000.00-444.1% | $3150000.00-14.9% | $3700000.00 |
| Diluted (in dollars per share) | -$10840000.00-444.1% | $3150000.00-14.9% | $3700000.00 |
| Basic (in shares) | 112.8M+0.1% | 112.7M+0.0% | 112.7M |
| Diluted (in shares) | 112.8M+0.1% | 112.7M+0.0% | 112.7M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.